He sensitivity of A549 and SAS cells to erlotinib (Fig. 3B
He sensitivity of A549 and SAS cells to erlotinib (Fig. 3B). Constitutive KRAS activity regulates clonogenic cell survival through the PI3K/Akt pathway but not MAPK/ERK signaling Transfection of mutated KRAS…